Clinical Trial Update: Phase 1 Study to Explore the Safety and Pharmacokinetics of DAPAglifozin in Adolescents and Adults With Type 1 Diabetes [Phase 1]

View source ↗

Summary

A Phase 1 trial assessing safety and pharmacokinetics of DAPAglifozin in adolescents and adults with Type 1 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 1 Diabetes Mellitus

Drugs mentioned

• DAPAglifozin (dapagliflozin)

Snippet

Sponsor: Kinderkrankenhaus auf der Bult | Conditions: Type 1 Diabetes | Phase 1 | Status: COMPLETED